537 related articles for article (PubMed ID: 21909104)
1. Glutamate release by primary brain tumors induces epileptic activity.
Buckingham SC; Campbell SL; Haas BR; Montana V; Robel S; Ogunrinu T; Sontheimer H
Nat Med; 2011 Sep; 17(10):1269-74. PubMed ID: 21909104
[TBL] [Abstract][Full Text] [Related]
2. Human glioma cells induce hyperexcitability in cortical networks.
Campbell SL; Buckingham SC; Sontheimer H
Epilepsia; 2012 Aug; 53(8):1360-70. PubMed ID: 22709330
[TBL] [Abstract][Full Text] [Related]
3. Sulfasalazine for brain cancer fits.
Sontheimer H; Bridges RJ
Expert Opin Investig Drugs; 2012 May; 21(5):575-8. PubMed ID: 22404218
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.
Chung WJ; Sontheimer H
J Neurochem; 2009 Jul; 110(1):182-93. PubMed ID: 19457125
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.
Robert SM; Buckingham SC; Campbell SL; Robel S; Holt KT; Ogunrinu-Babarinde T; Warren PP; White DM; Reid MA; Eschbacher JM; Berens ME; Lahti AC; Nabors LB; Sontheimer H
Sci Transl Med; 2015 May; 7(289):289ra86. PubMed ID: 26019222
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.
Sehm T; Fan Z; Ghoochani A; Rauh M; Engelhorn T; Minakaki G; Dörfler A; Klucken J; Buchfelder M; Eyüpoglu IY; Savaskan N
Oncotarget; 2016 Jun; 7(24):36021-36033. PubMed ID: 27074570
[TBL] [Abstract][Full Text] [Related]
9. Autocrine glutamate signaling promotes glioma cell invasion.
Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
[TBL] [Abstract][Full Text] [Related]
10. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
[TBL] [Abstract][Full Text] [Related]
11. Sulfasalazine decreases mouse cortical hyperexcitability.
Alcoreza O; Tewari BP; Bouslog A; Savoia A; Sontheimer H; Campbell SL
Epilepsia; 2019 Jul; 60(7):1365-1377. PubMed ID: 31211419
[TBL] [Abstract][Full Text] [Related]
12. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.
Ye ZC; Rothstein JD; Sontheimer H
J Neurosci; 1999 Dec; 19(24):10767-77. PubMed ID: 10594060
[TBL] [Abstract][Full Text] [Related]
13. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
14. Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
MacKenzie G; O'Toole KK; Moss SJ; Maguire J
Epilepsy Res; 2016 Oct; 126():185-96. PubMed ID: 27513374
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine decreases astrogliosis-mediated seizure burden.
Alcoreza O; Jagarlamudi S; Savoia A; Campbell SL; Sontheimer H
Epilepsia; 2022 Apr; 63(4):844-854. PubMed ID: 35132640
[TBL] [Abstract][Full Text] [Related]
16. Glioma-related seizures: glutamate is the key.
Simon M; von Lehe M
Nat Med; 2011 Oct; 17(10):1190-1. PubMed ID: 21988994
[No Abstract] [Full Text] [Related]
17. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Lange F; Hörnschemeyer J; Kirschstein T
Cells; 2021 May; 10(5):. PubMed ID: 34067762
[TBL] [Abstract][Full Text] [Related]
18. Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.
Buckingham SC; Robel S
Neurochem Int; 2013 Dec; 63(7):696-701. PubMed ID: 23385090
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
Sleire L; Skeie BS; Netland IA; Førde HE; Dodoo E; Selheim F; Leiss L; Heggdal JI; Pedersen PH; Wang J; Enger PØ
Oncogene; 2015 Dec; 34(49):5951-9. PubMed ID: 25798841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
